Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for depression and sleep in breast cancer
NCT01355523Phase 3Terminated
- Sponsor
- Melissa Voigt Hansen
- Start
- Jul 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in major depressive disorder (MDD), anxiety disorder, sleep disorder, cognitive dysfunction, sponsored by Melissa Voigt Hansen. Started Jul 2011; status: terminated.
02
Drugs
melatonin
03
Conditions
major depressive disorder (MDD)anxiety disordersleep disordercognitive dysfunction
Beyond the preview
Go deeper on NCT01355523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355523.